Picture of Irras AB logo

IRRAS Irras AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Irras Q2 Operating Loss Widens To SEK 35.8 Mln

July 22 (Reuters) - Irras AB  IRRAS.ST :
    * Q2 NET REVENUE AMOUNTED TO SEK 9.7 MILLION (5.1)
    * Q2 OPERATING LOSS (EBIT) AMOUNTED TO SEK 35.8 MILLION
(LOSS
26.7)
    * FINANCIAL TARGETS: REVENUE IS EXPECTED TO EXCEED MSEK 350
IN
2025 WITH A GROSS MARGIN ABOVE 60 PERCENT. CASHFLOW BREAKEVEN IS
EXPECTED BY 2025
    * IN 2022, REVENUES ARE EXPECTED TO EXCEED MSEK 35 WITH A
GROSS
MARGIN ABOVE 30 PERCENT.
    * COMPANY MAY CONSIDER A CHANGE IN ITS COMMERCIAL STRATEGY
BY
EXPLORING POTENTIAL PARTNERSHIPS WITH ESTABLISHED MEDICAL DEVICE
COMPANIES TO ACCELERATE ROLLOUT OF ITS PRODUCTS.

Source text for Eikon:  ID:nWkr3mRtrY 
Further company coverage:  IRRAS.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Irras AB

See all news